Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions

Objective: To compare the diagnostic performance for the detection of clinically significant prostate cancers and interobserver agreement between PI-RADS v2 and v2.1 Material and Method: The mpMRI images of 258 patients and 394 nodüles included in this retrospective study were obtained on 3T MR and...

Full description

Saved in:
Bibliographic Details
Main Authors: Mustafa Koplay, Ali Furkan Batur, Serdar Göktaş, Mehmet Kaynar, Halil Özer, Ahmet Baytok, Ömer Faruk Topaloğlu
Format: Article
Language:English
Published: Selcuk University Press 2024-04-01
Series:Genel Tıp Dergisi
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/3486252
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841562659437150208
author Mustafa Koplay
Ali Furkan Batur
Serdar Göktaş
Mehmet Kaynar
Halil Özer
Ahmet Baytok
Ömer Faruk Topaloğlu
author_facet Mustafa Koplay
Ali Furkan Batur
Serdar Göktaş
Mehmet Kaynar
Halil Özer
Ahmet Baytok
Ömer Faruk Topaloğlu
author_sort Mustafa Koplay
collection DOAJ
description Objective: To compare the diagnostic performance for the detection of clinically significant prostate cancers and interobserver agreement between PI-RADS v2 and v2.1 Material and Method: The mpMRI images of 258 patients and 394 nodüles included in this retrospective study were obtained on 3T MR and evaluated by two radiologists according to PI-RADS v2 and v2.1. Sensitivity and specificity between v2 and v2.1 compared. Detection rates for clinically significant prostate cancers of upgraded and downgraded lesions in the use of v2.1 from v2 were assessed. Interobserver agreement was assessed using κ statistics. Results: PI-RADS v2.1 and v2 showed higher sensitivity and lower specificity (100%, 52.38%) in peripheral zone and showed higher sensitivity and specificity (92.86%, 98.79%) in transition zone for category ≥4 lesions in the detection of csPCa, not significantly difference was found between the two versions. Interobserver agreement was statistically significant and very weak in the transition zone (κ=0.383, κ=0.279, respectively), very strong in the peripheral zone (κ=0.869) according to both classifications and they were similar. Conclusion: The diagnostic performance of PI-RADS v2 and v2.1 were found similar in detecting clinically significant cancers and all cancers in both zones. The clinically significant cancer detection rate in category 2+1 lesions in the transition zone was higher than in category 2 lesions but it wasn’t statistically significant. Interobserver agreement was low in the transition zone and very strong in the peripheral zone in both versions.
format Article
id doaj-art-cd150b44ca98418297842110dd0f7f41
institution Kabale University
issn 2602-3741
language English
publishDate 2024-04-01
publisher Selcuk University Press
record_format Article
series Genel Tıp Dergisi
spelling doaj-art-cd150b44ca98418297842110dd0f7f412025-01-03T00:46:51ZengSelcuk University PressGenel Tıp Dergisi2602-37412024-04-0134222322910.54005/geneltip.1378687154Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both VersionsMustafa Koplay0Ali Furkan Batur1Serdar Göktaş2Mehmet Kaynar3Halil Özer4Ahmet Baytok5Ömer Faruk Topaloğlu6SELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİSELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİSELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİSELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİSELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİSELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİSELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİObjective: To compare the diagnostic performance for the detection of clinically significant prostate cancers and interobserver agreement between PI-RADS v2 and v2.1 Material and Method: The mpMRI images of 258 patients and 394 nodüles included in this retrospective study were obtained on 3T MR and evaluated by two radiologists according to PI-RADS v2 and v2.1. Sensitivity and specificity between v2 and v2.1 compared. Detection rates for clinically significant prostate cancers of upgraded and downgraded lesions in the use of v2.1 from v2 were assessed. Interobserver agreement was assessed using κ statistics. Results: PI-RADS v2.1 and v2 showed higher sensitivity and lower specificity (100%, 52.38%) in peripheral zone and showed higher sensitivity and specificity (92.86%, 98.79%) in transition zone for category ≥4 lesions in the detection of csPCa, not significantly difference was found between the two versions. Interobserver agreement was statistically significant and very weak in the transition zone (κ=0.383, κ=0.279, respectively), very strong in the peripheral zone (κ=0.869) according to both classifications and they were similar. Conclusion: The diagnostic performance of PI-RADS v2 and v2.1 were found similar in detecting clinically significant cancers and all cancers in both zones. The clinically significant cancer detection rate in category 2+1 lesions in the transition zone was higher than in category 2 lesions but it wasn’t statistically significant. Interobserver agreement was low in the transition zone and very strong in the peripheral zone in both versions.https://dergipark.org.tr/tr/download/article-file/3486252pi-rads v2.1klinik olarak anlamlı prostat kanserigözlemciler arası uyumpi-rads v2.1clinically significant prostate cancerinterobserver agreement
spellingShingle Mustafa Koplay
Ali Furkan Batur
Serdar Göktaş
Mehmet Kaynar
Halil Özer
Ahmet Baytok
Ömer Faruk Topaloğlu
Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
Genel Tıp Dergisi
pi-rads v2.1
klinik olarak anlamlı prostat kanseri
gözlemciler arası uyum
pi-rads v2.1
clinically significant prostate cancer
interobserver agreement
title Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
title_full Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
title_fullStr Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
title_full_unstemmed Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
title_short Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
title_sort comparison of diagnostic performance of pi rads v2 and v2 1 and interobserver agreement in both versions
topic pi-rads v2.1
klinik olarak anlamlı prostat kanseri
gözlemciler arası uyum
pi-rads v2.1
clinically significant prostate cancer
interobserver agreement
url https://dergipark.org.tr/tr/download/article-file/3486252
work_keys_str_mv AT mustafakoplay comparisonofdiagnosticperformanceofpiradsv2andv21andinterobserveragreementinbothversions
AT alifurkanbatur comparisonofdiagnosticperformanceofpiradsv2andv21andinterobserveragreementinbothversions
AT serdargoktas comparisonofdiagnosticperformanceofpiradsv2andv21andinterobserveragreementinbothversions
AT mehmetkaynar comparisonofdiagnosticperformanceofpiradsv2andv21andinterobserveragreementinbothversions
AT halilozer comparisonofdiagnosticperformanceofpiradsv2andv21andinterobserveragreementinbothversions
AT ahmetbaytok comparisonofdiagnosticperformanceofpiradsv2andv21andinterobserveragreementinbothversions
AT omerfaruktopaloglu comparisonofdiagnosticperformanceofpiradsv2andv21andinterobserveragreementinbothversions